detect
viral
respiratori
agent
improv
last
decad
due
new
molecular
techniqu
avail
monoclon
antibodi
number
differ
viral
speci
garbino
et
al
legoff
et
al
rovida
et
al
nonetheless
major
episod
acut
respiratori
infect
none
pathogen
identifi
pediatr
well
adult
popul
griffin
et
al
louie
et
al
like
preval
viral
infect
underestim
larg
number
respiratori
virus
eventu
involv
respiratori
tract
infect
also
continu
increas
list
new
respiratori
pathogen
identifi
molecular
techniqu
contribut
significantli
burden
acut
respiratori
infect
inde
human
metapneumoviru
hmpv
detect
van
den
hoogen
et
al
consid
import
lower
respiratori
tract
pathogen
second
respiratori
syncyti
viru
rsv
judg
incid
rate
among
infant
children
van
den
hoogen
et
al
crow
end
follow
sar
coronaviru
outbreak
two
independ
research
group
report
discoveri
fourth
human
coronaviru
name
van
der
hoek
et
al
nh
esper
et
al
earli
detect
fifth
human
coronaviru
publish
research
group
hong
kong
woo
et
al
sever
report
confirm
retrospect
new
human
coronavirus
circul
differ
countri
worldwid
bastien
et
al
esper
et
al
woo
et
al
vabret
et
al
therefor
surveil
program
viral
agent
conduct
octob
septemb
children
hospit
acut
respiratori
infect
pediatr
depart
univers
la
sapienza
hospit
rome
molecular
approach
use
specif
revers
transcript
rt
pcr
assay
detect
nearli
respiratori
virus
includ
novel
coronavirus
adopt
main
aim
studi
estim
incid
respiratori
viral
agent
children
suffer
respiratori
tract
infect
character
differ
speci
pathogen
role
studi
conduct
octob
septemb
children
hospit
consecut
acut
respiratori
infect
relat
condit
umberto
hospit
pediatr
depart
univers
la
sapienza
rome
patient
enrol
diagnosi
asthma
asthma
consolid
bronchiol
bronchopneumonia
laringotracheo
bronchiti
exclus
criteria
underli
medic
problem
eg
prematur
congenit
diseas
cisti
fibrosi
inform
consent
obtain
parent
children
one
day
hospit
patient
underw
nasal
wash
obtain
ml
steril
salin
physiolog
solut
inject
nostril
collect
syring
sampl
deliv
ice
within
hr
virolog
laboratori
arriv
need
vortex
bead
solv
mucu
divid
two
aliquot
one
treat
nucleic
acid
extract
second
subaliquot
store
two
hundr
microlit
respiratori
specimen
subject
nucleic
acid
extract
use
total
nucleic
acid
isol
kit
roch
diagnost
mannheim
germani
elut
ml
suppli
elut
buffer
test
respiratori
virus
ml
rna
denatur
min
ad
ml
rtreaction
mix
contain
random
hexam
amersham
bioscienc
buckinghamshir
uk
mumlvrt
roch
incub
hr
follow
min
hand
rt
reaction
detect
hmpv
nh
perform
ad
reaction
mix
proper
specif
antisens
primer
panel
pcr
nest
pcr
assay
multiplex
format
develop
detect
respiratori
virus
includ
influenza
influenza
b
rsv
hcov
hcov
adenoviru
rhinoviru
hmpv
hcov
hcov
tabl
primer
specif
viru
select
publish
protocol
reaction
condit
optim
run
differ
reaction
thermal
profil
whenev
possibl
grondahl
et
al
viral
nucleic
acid
extract
describ
refer
virus
avail
virolog
laboratori
influenza
strain
valorn
rsv
type
coronavirus
adenoviru
type
rhinoviru
isol
respiratori
sampl
viral
cdna
dna
adenoviru
obtain
describ
low
copi
number
neg
control
nucleasefre
water
run
specif
pcr
assay
separ
aliquot
amplifi
materi
along
molecular
weight
marker
undertaken
electrophoresi
min
agaros
gel
pcr
reaction
produc
proper
band
purifi
qiaquick
pcr
purif
column
qiagen
hilden
germani
sequenc
confirm
posit
amplif
product
clone
use
topo
ta
clone
kit
invitrogen
carlsbad
ca
plasmid
dna
use
posit
control
pcr
reaction
pcr
reaction
optim
detect
input
plasmid
copi
rtpcr
assay
specif
hmpv
l
gene
valid
use
rna
transcrib
proper
cdna
clone
maggi
et
al
tabl
hcov
sought
use
three
differ
rtpcr
reaction
lack
posit
control
evalu
amplif
sensit
tabl
prior
test
respiratori
viru
random
primerdirect
rt
reaction
sampl
perform
describ
subject
pcr
amplif
invari
bactin
gene
rule
occurr
pcr
inhibitor
bactin
pcr
neg
specimen
reextract
frozen
aliquot
amplif
ml
cdna
templat
ml
nucleic
acid
adenoviru
detect
ad
ml
reaction
mix
contain
pmol
primer
mm
dntp
mm
mgcl
mm
mgcl
first
second
round
reaction
u
taq
polymeras
roch
posit
neg
control
run
reaction
pcr
product
electrophores
amplifi
fragment
purifi
sequenc
describ
sequenc
obtain
compar
nation
center
biotechnolog
inform
databas
ncbi
genebank
sever
viral
strain
type
accordingli
amplif
product
sequenc
confirm
true
posit
test
second
specimen
aliquot
studi
carri
year
children
hospit
acut
respiratori
infect
relat
condit
pediatr
depart
least
day
subject
median
age
month
rang
month
children
least
one
viral
pathogen
identifi
infect
one
viru
investig
dual
infect
total
virus
identifi
patient
neg
respiratori
viru
test
tabl
ii
show
result
percentag
case
consid
virusposit
case
common
agent
rsv
follow
rhinoviru
approxim
half
pcramplifi
fragment
sequenc
randomli
along
studi
period
confirm
posit
result
eventu
type
virus
twenti
total
rsv
isol
sequenc
sequenc
homolog
show
subtyp
b
multiplex
pcr
influenza
reveal
posit
influenza
influenza
b
confirm
sequenc
hmpv
present
eight
case
posit
pcr
assay
use
sequenc
analysi
reveal
type
six
sampl
posit
multiplex
pcr
hcov
confirm
sequenc
hcov
sequenc
identifi
confirm
one
case
amplifi
coupl
primer
genom
region
van
der
hoek
et
al
nh
primer
esper
et
al
hcov
sought
retrospect
frozen
aliquot
sampl
octob
may
time
origin
paper
publish
woo
et
al
posit
found
either
frozen
fresh
sampl
nonetheless
rtpcr
assay
use
studi
properli
valid
due
lack
posit
control
dual
infect
contribut
total
posit
case
present
case
coinfect
rsv
rhinoviru
case
includ
rsvrhinoviru
doubl
infect
tabl
iii
season
age
distribut
respiratori
virus
detect
studi
accord
previou
report
griffin
et
al
monto
nicholson
et
al
rsv
circul
winter
littl
activ
outsid
month
circul
influenza
virus
similar
rsv
case
detect
outsid
winter
peak
case
influenza
b
detect
appar
end
influenza
circul
earli
spring
hmpv
distribut
limit
winter
month
present
second
peak
infect
june
respiratori
virus
detect
year
coinfect
detect
frequent
exclus
winter
month
tabl
iv
distribut
detect
virus
accord
patient
age
shown
rsv
far
common
pathogen
affect
newborn
month
present
virusinfect
infant
follow
hmpv
infect
incid
rsv
infect
decreas
dramat
age
age
month
age
year
older
children
rhinoviru
pathogen
identifi
frequent
children
older
year
present
studi
describ
virolog
test
molecular
method
nasal
wash
hospit
children
suffer
acut
respiratori
infect
nasal
lavag
chosen
simpler
less
invas
obtain
respiratori
specimen
pediatr
age
signific
also
viral
lower
tract
respiratori
infect
inde
nasal
wash
taken
acut
phase
ill
though
proven
seroconvers
reason
consid
detect
viru
princip
pathogen
involv
present
studi
includ
bacteri
pathogen
atyp
respiratori
viral
pathogen
eg
cytomegaloviru
nevertheless
comprehens
array
amplificationbas
test
perform
determin
burden
respiratori
virus
expect
pediatr
popul
rsv
common
agent
case
posit
case
detect
mainli
bronchiol
case
pneumonia
case
present
studi
rsv
infect
start
decemb
end
juli
recent
studi
describ
differ
season
distribut
rsv
infect
diagnos
enzym
immunoassay
italian
children
medici
et
al
rsv
epidem
start
octobernovemb
end
may
show
peak
incid
februari
peak
incid
similar
januarymarch
present
studi
case
detect
also
june
juli
differ
sensit
assay
use
may
possibl
explain
discrep
detect
sporad
rsv
respiratori
viru
infect
could
contribut
surviv
virus
summer
rhinoviru
second
common
viral
pathogen
detect
present
year
rhinoviru
repres
coinfect
case
figur
probabl
reflect
high
preval
upper
respiratori
infect
children
legg
et
al
author
report
respiratori
picornavirus
one
lead
etiolog
caus
bronchiol
french
infant
jacqu
et
al
present
studi
half
patient
rhinoviru
sole
respiratori
pathogen
affect
pneumonia
addit
detect
four
children
hospit
asthma
episod
recent
studi
indic
rhinoviru
respons
direct
infect
lower
airway
epithelium
papadopoulo
et
al
furthermor
abl
replic
bronchial
epithelium
vitro
vivo
mosser
et
al
consist
report
studi
suggest
involv
rhinoviru
case
pneumonia
actual
proport
lower
airway
pathogen
rhinoviru
follow
natur
infect
remain
assess
overal
children
year
hmpv
infect
repres
viral
ill
valu
slightli
lower
report
recent
northern
itali
studi
rome
hmpv
type
detect
contrast
report
identifi
type
winterspr
season
studi
popul
hmpv
case
occur
two
peak
infect
former
winter
latter
june
interestingli
winter
associ
bronchiol
children
younger
month
wherea
june
pneumonia
patient
month
year
old
human
coronavirus
consid
agent
upper
respiratori
tract
diseas
includ
common
cold
nonetheless
report
caus
seriou
respiratori
ill
children
age
year
coronaviru
case
caus
serotyp
five
affect
pneumonia
one
laryng
patient
year
old
child
infect
hospit
acut
respiratori
infect
subsequ
clinic
diagnosi
met
criteria
attribut
kawasaki
diseas
obvious
one
case
contribut
associ
infect
kawasaki
diseas
esper
et
al
shimizu
et
al
case
report
confirm
circul
itali
first
report
manuscript
prepar
northern
itali
detect
winterspr
season
well
known
infant
sever
bronchiol
increas
risk
develop
recurr
wheez
later
life
virus
rsv
multipl
viral
infect
may
contribut
sever
bronchiol
report
papadopoulo
et
al
sempl
et
al
dual
infect
hmpv
rsv
rhinoviru
rsv
confer
increas
sever
diseas
children
admit
pediatr
intens
care
unit
contrast
studi
report
coinfect
two
respiratori
virus
significantli
associ
diseas
sever
van
woensel
et
al
wolf
et
al
present
studi
dual
infect
detect
virusposit
case
mainli
children
pneumonia
clinic
data
avail
coinfect
children
show
signific
differ
patient
larger
studi
need
clarifi
issu
whether
multipl
infect
could
involv
sever
low
respiratori
tract
infect
respiratori
viru
infect
continu
undiagnos
misdiagnos
lack
reliabl
immunoassay
notabl
except
rsv
influenza
complex
monoclon
antibodiesand
pcrbase
test
season
geograph
distribut
pathogen
role
newli
identifi
viral
pathogen
virus
consid
mild
pathogen
rhinoviru
coronaviru
assess
given
reliabl
identif
undertaken
recent
outbreak
sarscov
possibl
emerg
recombin
avianhuman
influenza
viru
given
nonspecif
initi
sign
symptom
patient
indic
advantag
rapid
diagnosi
respiratori
infect
avail
new
class
drug
activ
influenza
b
forthcom
use
drug
target
rsv
rhinoviru
adenovirus
encourag
reliabl
detect
respiratori
virus
